Literature DB >> 29360485

Development of a Clinically Relevant Men's Health Phenotype and Correlation of Systemic and Urologic Conditions.

Daniel A Shoskes1, Sarah C Vij2, Aaron Shoskes1, Yaw Nyame1, Tianming Gao1.   

Abstract

OBJECTIVE: To develop a clinically relevant men's health phenotype and investigate the correlation between severity of urologic symptoms and systemic health conditions
METHODS: Retrospective chart review was performed for men seeking care for benign prostatic hypertrophy, erectile dysfunction or chronic prostatitis or chronic pelvic pain syndrome. Urologic symptoms were assessed with the International Prostate Symptom Score, Sexual Health Inventory for Men, and National Institute of Health Chronic Prostatitis Symptom Score. Each was graded as absent or mild (0), moderate (1), or severe (2) and totaled for a urologic score (US). Seven comorbidities with known impact on urologic symptoms were similarly graded (0-2 for each) and totaled for a systemic score (SS). These domains were anxiety, cardiovascular, testosterone deficiency, insulin (diabetes), obesity, neurologic, and sleep apnea.
RESULTS: The study included 415 men with median age of 53.8 (range 19-92). Mean total US was 2.1 (range 0-6) and mean SS was 4.1 (0-12). There was a strong correlation between US and SS (Spearman Rho = 0.37, P < .00001) which was consistent regardless of age. The hierarchy of systemic condition impact on US was cardiovascular> neurologic> diabetes> anxiety> sleep apnea> obesity> testosterone. By cluster analysis the tightest correlations were age with cardiovascular, anxiety with CPPS, and diabetes with erectile dysfunction.
CONCLUSION: Systemic health conditions correlate strongly with urologic symptoms in men who present for urologic care. Phenotyping with ACTIONS (anxiety, cardiovascular, testosterone deficiency, insulin, obesity, neurologic, sleep apnea) can identify modifiable conditions that may impact urologic symptoms and outcome of interventions. Future validation in the general population is needed.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29360485     DOI: 10.1016/j.urology.2017.12.035

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  3 in total

1.  Men's health in Canada: A national survey of urologists.

Authors:  Nahid Punjani; Andrew Di Pierdomenico; Larry Goldenberg; Gerald Brock; Ryan Flannigan
Journal:  Can Urol Assoc J       Date:  2021-01       Impact factor: 1.862

2.  Failure of testosterone replacement therapy to improve symptoms correlates with burden of systemic conditions.

Authors:  Nicholas J Farber; Sarah C Vij; Daniel A Shoskes
Journal:  Transl Androl Urol       Date:  2020-06

3.  Graminex Pollen: Phenolic Pattern, Colorimetric Analysis and Protective Effects in Immortalized Prostate Cells (PC3) and Rat Prostate Challenged with LPS.

Authors:  Marcello Locatelli; Nicola Macchione; Claudio Ferrante; Annalisa Chiavaroli; Lucia Recinella; Simone Carradori; Gokhan Zengin; Stefania Cesa; Lidia Leporini; Sheila Leone; Luigi Brunetti; Luigi Menghini; Giustino Orlando
Journal:  Molecules       Date:  2018-05-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.